Biomarker platelet assessment type

General Details:

Name:
Biomarker platelet assessment type
Steward:
NINDS
Definition:
Type of biomarker(s) assessed from platelets (high OXPHOS) samples.
Registration Status:
Qualified

Permissible Values:

Value Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
OXPHOS enzymology OXPHOS enzymology OXPHOS enzymology
High resolution respirometry High resolution respirometry High resolution respirometry
Coenzyme Q10 Coenzyme Q10 Coenzyme Q10
Peripheral type benzodiazerpine Peripheral type benzodiazerpine Peripheral type benzodiazerpine

Designations:

Designation:
Biomarker platelet assessment type
Tags:
Designation:
Which biomarker(s) were assessed from the specimen's platelets (high OXPHOS) sample?
Tags:
Question Text

Designations:

Definition:
Type of biomarker(s) assessed from platelets (high OXPHOS) samples.
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
Kramer, P.A., et al., A Review of the Mitochondrial and Glcolytic Metabolism in Human Platelets and Leukocytes: Implications for their Use as Bioenergetic Biomarkers. REdox Biol, 2014. 2: P. 206-210. Hroudova, J., et al., Mitochondrial Respiration in Blood Platelets of Depressive patients. Mitochondrion, 2013. 13(6): P. 795-800. Martini, C., ET AL., Peripheral Benzodiazepine Binding Sites in Platelets of Patients Affected by Mitochondrial Diseases and Large Scale Mitochondrial DNA Rearrangements. Mol Med, 2002. 8(12): P. 841-6.

Identifiers:

Source:
NLM
Id:
XkWKxUV5sHC
Version:
1.1
Source:
NINDS
Id:
C19561
Version:
1
Source:
BRICS Variable Name
Id:
BiomarkPlatAssessTyp
Version: